Liquefaction of bone matrix
The invention relates to methods of preparing a bone matrix solution, a bone matrix implant, and variants thereof. The invention also relates to methods of cell culture using the same. The invention further relates to bone matrix scaffolds comprising one or more bone matrix nanofibers, methods of preparing, and methods of use thereof. The invention also relates to methods of culturing cells and promoting differentiation of stem cells using the same.
1. A synthetic surface partly or wholly coated with a bone matrix, said matrix comprising a solution of bone in an anhydrous solvent, said solvent comprising (i) hexafluoroisopropanol (HFP) or 2,2,2-trifluoroethanol (TFE) and (ii) trifluoroacetic acid (TFA), said matrix being in the form of a colloidal gel.
2. An implant comprising the synthetic surface of claim 1 .
3. The synthetic surface of claim 1 , wherein the bone comprises demineralized bone matrix.
4. The synthetic surface of claim 1 , wherein the bone comprises collagen Type I, wherein more than 60% of the collagen Type I is in its native structure.
5. A method of making a synthetic surface, comprising the steps of:
a) preparing a bone matrix solution by dissolving bone in an amount of an anhydrous solvent comprising (i) hexafluoroisopropanol (HFP) or 2, 2, 2-trifluoroethanol (TFE) and (ii) trifluoroacetic acid (TFA) sufficient to form the bone matrix solution at a temperature lower than about 25° C.;
b) exposing the bone matrix solution to conditions sufficient to evaporate a portion of the solvent to form a colloidal gel;
c) coating a synthetic surface with the colloidal gel; and
d) exposing the coated surface to conditions sufficient to further evaporate an amount of solvent.
6. The method of claim 5 , wherein the dissolved bone comprises demineralized bone matrix.
7. The method of claim 5 , wherein the dissolved bone comprises collagen Type I, wherein more than 60% of the collagen Type I is in its native structure.